Nutex Health Executive Compensation (FY25)
NUTX · Executive and director compensation, fiscal 2023 to 2025
Chief executive, fiscal 2025 ◇ Thomas Vo | Median of the other named officers $716,585 5 officers, excluding the chief executive | Latest say-on-pay support = April 23, 2026 |
Velarion Member: every covered company in one industry, with dashboards, peer screens and board-ready briefs. Three seats, one year.
The paid brief on Nutex Health
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
Data as of October 22, 2026Latest filing (8-K): April 23, 2026
8 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Member, one year
135 figures on this page: 131 cited to the filing that reported them, 4 calculated from figures it prints. See the citations
More on Nutex Health
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Thomas Vo: $1,162,214 → $2,197,420 (89.1% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is Nutex Health's chief executive and what were they paid?
Thomas Vo was paid $2,197,420 in total compensation as Chief Executive Officer and Chairman of the Board for fiscal 2025. Compared with the $1,162,214 reported for fiscal 2024, Vo's total was 89.1% higher.
What was Nutex Health's say-on-pay result?
Shareholders supported the say-on-pay proposal with 94.8% of votes cast including abstentions in favor at the meeting held April 23, 2026 for fiscal 2025.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Thomas Vo Chief Executive Officer | ◇ | — | — | — | — | — | ◇ | ◇ |
Warren Hosseinion President | ◇ | — | — | — | — | — | ◇ | ◇ |
Jon Bates Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | — | ◇ |
Michael Chang Chief Medical Officer | ◇ | — | — | — | — | — | ◇ | ◇ |
Joshua DeTillio Former Chief Operating Officer | ◇ | — | — | — | — | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Warren Hosseinion President | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Thomas Vo Chief Executive Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Joshua DeTillio Chief Operating Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Jon Bates Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Michael Chang Chief Medical Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Thomas Vo Chief Executive Officer and Chairman of the Board | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Warren Hosseinion President | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Joshua DeTillio Former Chief Operating Officer Departed during or after this year | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Jon Bates Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | — not reconciled |
Michael Chang Chief Medical Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Wesley Bamburg Chief Operating Officer | ◇ | ◇ | — | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Jon Bates | PSU | — | — | — | — | — | — | ◇ |
| Joshua DeTillio | PSU | — | — | — | — | — | — | ◇ |
| Michael Chang | OTHER | — | — | — | — | — | — | ◇ |
| Thomas Vo | PSU | — | — | — | — | — | — | ◇ |
| Warren Hosseinion | PSU | — | — | — | — | — | — | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Warren Hosseinion | PSU | ◇ | ◇ | — | — |
| Thomas Vo | PSU | ◇ | ◇ | — | — |
| Michael Chang | PSU | ◇ | ◇ | — | — |
| Jon Bates | PSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Jon Bates
Chief Financial Officer · Terms as described in the company’s compensation discussion · citing a 2025 filing
| Severance multiple | ◇ |
| Severance base | ◇ |
| Benefits continuation | ◇ |
Joshua DeTillio
Former Chief Operating Officer · Terms as described in the company’s compensation discussion · citing a 2025 filing
| Severance multiple | ◇ |
| Severance base | ◇ |
| Benefits continuation | ◇ |
Thomas Vo
Chief Executive Officer and Chairman of the Board · Terms as described in the company’s compensation discussion · citing a 2025 filing
| Severance multiple | ◇ |
| Severance base | ◇ |
Warren Hosseinion
President · Terms as described in the company’s compensation discussion · citing a 2025 filing
| Severance multiple | ◇ |
| Severance base | ◇ |
| Benefits continuation | ◇ |
Wesley Bamburg
Chief Operating Officer · Employment agreement · citing a 2025 filing
| Severance multiple | ◇ |
| Change-in-control trigger | ◇ |
| Equity acceleration on change in control | ◇ |
| Benefits continuation | ◇ |
| Excise tax treatment | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Michael L. Reed Lead independent director | ◇ | ◇ | — | — | — | — | ◇ |
Cheryl Grenas | ◇ | ◇ | — | — | — | — | ◇ |
Scott J. Saunders | ◇ | ◇ | — | — | — | — | ◇ |
Mitchell Creem | ◇ | — | — | — | — | — | ◇ |
Frank E. Jaumot | ◇ | ◇ | — | — | — | — | ◇ |
Thomas T. Vo, Kelvin Spears and Warren Hosseinion served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Lead independent director premium | ◇ |
| Audit committee chair | ◇ |
| Compensation committee chair | ◇ |
| Nominating and governance chair | ◇ |
Equity is delivered as restricted stock units.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | April 23, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | July 14, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | June 17, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | June 29, 2023 | = | ◇ | ◇ | ◇ |
Velarion Pro: every company page, peer tools and exports, one seat
One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Thomas Vo (Chief Executive Officer and Chairman of the Board), FY2025 total compensation $2,197,420 (base salary $1,000,000) [exec_comp, SEC accession 0001628280-26-017681, filed 2026-03-13]What this page does not include
Everything above is a fact Nutex Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
135 figures on this page: 131 cited to the filing that reported them, 4 calculated from figures it prints.
131 cited to the filing
4 calculated from the filing
Documents cited
- 0001628280-26-026828
- 0001628280-26-017681Director Compensation · EXECUTIVE COMPENSATION · Summary Compensation Table
- 0001628280-25-035002Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001479681-25-000035Compensation Discussion and Analysis
- 0001079973-24-000910
- 0001104659-24-057492Summary Compensation Table
- 0001558370-23-011705
- 0001479681-25-000083EX-10.1
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Nutex Health executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/NUTX (accessed 2026).
Short form: data: Velarion
The paid brief for Nutex Health
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$1,500 for the Executive Compensation Report. Both reports for $2,400.
8 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Nutex Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}